Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

Delayed Quote. Delayed  - 08/26 10:14:59 pm
91.24 USD   +0.68%
08/08 DEXCOM : Launches New Clinic Portal for the DexCom CLARITY® Diabetes..
08/03 DEXCOM : Announces Upcoming Conference Presentations
08/02 DEXCOM : reports 2Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
90.56(c) 92.09(c) 90.35(c) 90.62(c) 91.24(c) Last
263 390 558 137 797 856 315 692 476 590 Volume
-0.42% +1.69% -1.89% +0.30% +0.68% Change
More quotes
Financials ($)
Sales 2016 576 M
EBIT 2016 -48,4 M
Net income 2016 -48,5 M
Finance 2016 4,89 M
Yield 2016 -
Sales 2017 796 M
EBIT 2017 22,0 M
Net income 2017 23,0 M
Finance 2017 9,26 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 327,49
EV / Sales2016 13,3x
EV / Sales2017 9,61x
Capitalization 7 654 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
08/18 DEXCOM : Launches New Clinic Portal for the DexCom CLARITY® Diabetes Management ..
08/08 DEXCOM : Launches New Clinic Portal for the DexCom CLARITY® Diabetes Management ..
08/03 DEXCOM : Announces Upcoming Conference Presentations
08/02 DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
08/02 DEXCOM : reports 2Q loss
08/02 DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
08/02 DEXCOM, INC. : Reports Second Quarter 2016 Financial Results
07/28 DEXCOM : FDA Posts Briefing Documents Ahead of Advisory Committee Meeting
07/22DJDEXCOM : Shares Rise After FDA Panel Vote
07/22 DEXCOM : FDA Advisory Committee Votes in Favor of Non-Adjunctive Label for DexCo..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
08/23 INSIDERINSIGHTS.COM DAILY ROUND UP 8 : WisdomTree Investments, Zosano Pharma, Vi..
08/22 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2016 Update
08/05 You Need A Web Presence - Cramer's Mad Money (8/4/16)
08/02 DexCom (DXCM) Kevin Ronald Sayer on Q2 2016 Results - Earnings Call Transcrip..
08/02 DexCom -5.7% as loss widens in Q2
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 96,6 $
Spread / Average Target 5,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terry H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Jess Roper Chief Financial Officer & Senior Vice President
Jorge A. Valdes Chief Technology Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.11.40%7 654
MEDTRONIC PLC12.58%120 679
ZIMMER BIOMET HOLDINGS..26.24%25 904
BAXTER INTERNATIONAL I..23.67%25 661
C R BARD INC14.59%15 945
TERUMO CORP9.16%15 099
More Results